Results 231 to 240 of about 71,732 (355)

Monitoring and Managing of Ergot Alkaloids in Cereal Grains: A Comprehensive Analysis of Analytical Challenges, Sampling Uncertainty, and Processing for Food Safety

Comprehensive Reviews in Food Science and Food Safety, Volume 25, Issue 3, May 2026.
ABSTRACT Ergot alkaloids (EAs), toxic secondary metabolites produced by Claviceps purpurea, pose food and feed safety concerns for cereal grains, particularly rye and wheat. While EAs are most frequently associated with rye, their occurrence in other cereals has been increasingly reported across diverse regions.
Chamali Kodikara, Nandika Bandara, Sheryl A. Tittlemier   +2 more
wiley   +1 more source

Effect of the central dopamine and serotonin receptor agonist on biogenic amines release in rats brain with experimental model of attention deficit hyperactivity disorder (ADHD) in vivo brain microdialysis study

, 2001
Przemysław Nowak, R Brus, Ryszard Szkilnik, Richard M. Kostrzewa   +3 more
openalex   +1 more source

1-(2-Aminoethyl)-3-methyl-8,9-dihydropyrano[3,2-e]indole: a rotationally restricted phenolic analog of the neurotransmitter serotonin and agonist selective for serotonin (5-HT2-type) receptors

, 1992
John E. Macor, Carol B. Fox, Celeste Johnson, B. Kenneth Koe, Lorraine A. Lebel, Stevin H. Zorn   +5 more
openalex   +1 more source

Unveiling the Demographics and Clinical Characteristics of Diabetic Neuropathy: Findings From the National Health Insurance Service, 2012–2017

Journal of Diabetes, Volume 18, Issue 5, May 2026.
Diabetic neuropathy prevalence declined from 23.4% to 21.5% between 2012 and 2017. About half received treatment, mainly α‐lipoic acid monotherapy; patients were older with comorbidities, leading to more hospitalizations. ABSTRACT Background Diabetic neuropathy (DN) is the most common chronic complication of Type 2 diabetes mellitus (T2DM), with ...
Su Jin Jeong, Sun Keun Kim, Chong Hwa Kim   +2 more
wiley   +1 more source

The Effect of GLP-1 Receptor Agonists on Epilepsy: No Appetite for Seizures. [PDF]

Epilepsy Curr
Karakis I.
europepmc   +1 more source

Structural optimizations and bioevaluation of N-H aporphine analogues as Gq-biased and selective serotonin 5-HT2C receptor agonists

Jianmin Chen, Shao-Wen Tian, W Shui, Huilin Yang, Qing Mao, Nan Ye, X.-P Huang, Xuechu Zhen, Xin, Y, Wenming Qin, B Zhang   +10 more
openalex   +1 more source

The GLP-1 Receptor Agonist Liraglutide Decreases Primary Bile Acids and Serotonin in the Colon Independently of Feeding in Mice [PDF]

Katsunori Nonogaki, Takao Kaji
openalex   +1 more source

Pharmacological and Mechanistic Interventions for Cognitive Impairment Associated With Schizophrenia: A Review of Registered Clinical Trials

Acta Psychiatrica Scandinavica, Volume 153, Issue 5, Page 402-431, May 2026.
ABSTRACT Background Schizophrenia is characterized by positive, negative, and cognitive symptoms. Current pharmacological treatments often fail to address cognitive deficits. In this review of clinical trials, we aim to identify studies that explore neurobiological (non‐psychological) strategies to address Cognitive Impairment Associated with ...
Bahareh Peyrovian, Lena Palaniyappan, Theodore T. Kolivakis, Howard C. Margolese   +3 more
wiley   +1 more source

The Intestinal Cues Promoting Serotonin Release From the Human Gut. [PDF]

Cell Mol Gastroenterol Hepatol
Di Rienzi SC.
europepmc   +1 more source

Improved synthesis and physicochemical characterization of the selective serotonin 2A receptor agonist 25CN-NBOH [PDF]

Adrian G. Rossebø, Hannah G. Kolberg, Anders E. Tønder, Louise Kjærulff, Poul Erik Hansen, Karla Frydenvang, Jesper Østergaard, Jesper L. Kristensen   +7 more
openalex   +1 more source